218
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Additive effects of rapamycin and aspirin on dendritic cell allostimulatory capacity

, , , , &
Pages 434-441 | Received 14 Oct 2014, Accepted 03 Aug 2015, Published online: 14 Oct 2015
 

Abstract

Acting as antigen presenting cells, mature dendritic cells (DCs) initiate both innate and adaptive alloimmune responses. However, immature DCs are weak immunostimulators and mediate tolerogenic effects under certain conditions. Tolerogenic activities of immature DCs can be enhanced by pharmacological agents. Here, we compared pharmacological DC preconditioning with rapamycin and aspirin, applied alone or in combination, on LPS-induced DC maturation and T-cell allostimulatory capacity. Preconditioning with aspirin but not rapamycin tended to reduce the number of mouse bone marrow-derived immature DCs expressing CD40 and major histocompatibility complex class II molecules upon LPS stimulation. Conversely, DC preconditioning with rapamycin, but not aspirin, reduced T-cell alloproliferative responses. A combination of rapamycin and aspirin was more effective than either drug applied alone with respect to inhibition of T-cell alloproliferation. The two agents in combination reduced numbers of CD4+IFN-γ+ Th1 and CD4+IL-17+ Th17 effector cells while maintaining Foxp3+ regulatory T cells. These results suggest aspirin may moderately enhance rapamycin-mediated inhibition of DC allostimulatory capacity.

Acknowledgements

This work was supported by research grants from the Swiss National Science Foundation (310030-118210), the Fondation Vaudoise de Cardiologie and the Fondation Emma Muschamp (Lausanne) to G.V., and by grants from the Fondation Medi-CAL Futur and the Fondation Pierre Mercier pour la Science to J-C.W. and D.G.

Disclosure

The authors have no conflict of interest to disclose.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.